L
Louise Lansbury
Researcher at University of Nottingham
Publications - 20
Citations - 2495
Louise Lansbury is an academic researcher from University of Nottingham. The author has contributed to research in topics: Cohort study & Retrospective cohort study. The author has an hindex of 13, co-authored 20 publications receiving 1583 citations. Previous affiliations of Louise Lansbury include Nottingham University Hospitals NHS Trust & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Co-infections in people with COVID-19: a systematic review and meta-analysis.
TL;DR: A low proportion of COVID-19 patients have a bacterial co-infection; less than in previous influenza pandemics; and these findings do not support the routine use of antibiotics in the management of confirmed CO VID-19 infection.
Journal ArticleDOI
Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Marlieke E. A. de Kraker,Martin Wolkewitz,Peter Davey,Walter Koller,Jutta Berger,Jan Nagler,Claudine Icket,Smilja Kalenić,Jasminka Horvatić,Harald Seifert,Achim J. Kaasch,O. Paniara,Athina Argyropoulou,Maria Bompola,Edmond Smyth,Mairead Skally,Annibale Raglio,Uga Dumpis,Agita Melbarde Kelmere,Michael Borg,Deborah Xuereb,Mihaela C. Ghita,Michelle Noble,Jana Kolman,Stanko Grabljevec,David P. J. Turner,Louise Lansbury,Hajo Grundmann +27 more
TL;DR: Irrespective of methicillin susceptibility, S. aureus BSI has a significant impact on morbidity and mortality and in addition, MRSA BSI leads to a fatal outcome more frequently than MSSA B SI.
Journal ArticleDOI
Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies
Louise Lansbury,Fiona Bath-Hextall,Fiona Bath-Hextall,William Perkins,Wendy Stanton,Jo Leonardi-Bee +5 more
TL;DR: Assessment of the effects of treatments for non-metastatic invasive squamous cell carcinoma of the skin using evidence from observational studies to improve the evidence base for this common cancer and to optimise clinical management found many observational studies have looked at different treatment modalities for SCC.
Journal ArticleDOI
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins
M. de Kraker,Martin Wolkewitz,Peter Davey,Walter Koller,Johannes Berger,Jan Nagler,Claudine Icket,Smilja Kalenić,Jasminka Horvatić,Harald Seifert,Achim J. Kaasch,O. Paniara,Athina Argyropoulou,Maria Bompola,Edmond Smyth,M. Skally,Annibale Raglio,Uga Dumpis,A. Melbarde Kelmere,Michael Borg,Deborah Xuereb,Mihaela C. Ghita,M. Noble,Jana Kolman,Stanko Grabljevec,Dunja Turner,Louise Lansbury,Hajo Grundmann +27 more
TL;DR: Morbidity and mortality attributable to third-generation-cephalosporin-resistant E. coli BSI is significant and if prevailing resistance trends continue, high societal and economic costs can be expected.
Journal ArticleDOI
Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis.
TL;DR: Coricosteroid treatment in influenza is associated with increased mortality and hospital-acquired infection, but the evidence relates mainly to high corticosteroid doses and is of low quality with potential confounding by indication a major concern.